The Drugs Controller General of India (DCGI) on Friday granted the Serum Institute of India permission to manufacture Russian Covid-19 vaccine Sputnik V in India.
The Serum Institute of India (SII) has been granted approval to manufacture the vaccine for examination, test and analysis with certain conditions at its licensed facility in Hadapsar, Pune. The SII had submitted an application to the DCGI in this regard on Wednesday.
The Pune-based company has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia to develop Sputnik V in India.
SII is already producing the Oxford AstraZeneca Covid-19 vaccine under the name ‘Covishield’ and has told the government it will supply 10 crore doses of it in June. The Serum Institute is also manufacturing the Novavax vaccine, the regulatory clearance for which is awaited from the US.
Dysautonomia: The Silent Illness Impacting Millions of People Worldwide Dysautonomia is an umbrella term used…
https://youtu.be/mdl3AFFFcuk?si=i2cYzTX7WJ-z6wRp Does Chyawanprash Help in Cough & Cold? Exploring Its Benefits and Efficacy Chyawanprash, a…
Walk In Winter: In winter, the time from 7:00 AM to 9:00 AM is considered…
Does Maida Stick To Your Gut Lining: In this article, we debunk the common myth…
https://youtu.be/4NTKSfNf1TM?si=Y4xkEOKDUvqpIEZt The Disadvantages of Heating Packaged Milk Milk is a staple in many households and…
A recent study has revealed a growing mental health crisis among teenagers globally, with nearly…